Organization

UNIV Lyon-Université Claude Bernard Lyon 1

3 abstracts

Abstract
PRadR: PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer, a multicentric phase I/II.
Org: Institut de Recherche en Cancérologie de Montpellier, Inserm U1296, Department of Nuclear Medicine, Grenoble Alpes University Hospital, Nuclear Medicine Department, Centre Jean Perrin, UNIV Lyon-Université Claude Bernard Lyon 1,
Abstract
Blinded-assessment of a solution to evaluate olaparib maintenance treatment efficacy in patients with ovarian cancer from the GINECO/ENGOT PAOLA-1 trial.
Org: Centre Léon Berard, UNIV Lyon-Université Claude Bernard Lyon 1, Genotypos M.S.A., Genotypos Science Labs, AGO Study Group & Ev. Kliniken Essen-Mitte,
Abstract
Artificial intelligence–based biomarkers of response to immunotherapy in patients with non–small-cell lung cancer considering previous lines of treatment.
Org: ArianaPharma, Centre Leon Berard, Centre Léon Bérard, AP-HP at Saint-Louis Hospital, University Claude Bernard Lyon 1,